妈富隆改善围绝经期症状疗效观察

下载PDF

导出

摘要资料与方法选择我院妇科门诊自2007年2月～2009年4月42例健康不吸烟的围绝经期妇女口服妈富隆治疗。患者年龄在42～50岁,平均42.6±4.3岁。患者既往月经规律,近半年来出现月经紊乱且有不同程度的更年期症状,潮热出汗,Kupperman评分≥8分,无肝肾疾病。

作者杨慧菊

机构地区易门县人民医院妇产科

出处《云南医药》 CAS 2010年第6期664-665,共2页 Medicine and Pharmacy of Yunnan

关键词妈富隆围绝经期疗效

参考文献2

1TORPY JM, LYNM C, GLASS RM. Perimenopause: beginning of menopause[J]. JAMA, 2003, 289(7): 940.
2季芳 ,刘晓瑷 .口服避孕药在围绝经期的应用[J].国外医学（计划生育分册）,2004,23(2):67-70. 被引量：3

1Williams JK. Contraceptive needs of the perimenopausal woman.Obstet Gynecol Clin North Am, 2002,29(3):575-588.
2Burkman RT.Introduction.Am J Obstet Gynecol,2001,185:S1-3.
3Kaunitz AM.Oral contraceptive use in perimenopause. Am J Obstet Gynecol,2001,185:S32-37.
4Torpy JM, Lynm C, Glass RM. Perimenopause: beginning of menopause.JAMA,2003,289(7): 940.
5Miller L, Notter KM. Menstrual reduction with extended use of combined oral contraceptive pills:randomized controlled trial.Obstet Gynecol.2001,98:771-778.
6Michaelsson K,Baron JA,Farahmand BY, et al. Oralcontraceptive use and 3risk of hip fracture:a casecontrol study.Lancet,1999,353: 1481-1484.
7Pasco JA,Kotowicz MA,Henry MJ,et al.Oral contraceptives and bonemineral density:a population-based study. Am J Obstet Gynecol,2000,182:265 -269.
8Riman T,Dickman PW, Nilsson S, et al. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study.Am J Epidemlol,2002, 156(4): 363-373.
9Esthoff C,Britton JA,Gammon MD,et al.Oral contraceptive and benignovarian tumors.Am J Epidemiol,2000,152:242-246.
10Burkman RT. Reproductive hormones and cancer, ovarian and coloncancer. Obstet Gynecol Clin North Am, 2002,29(3): 527-540.

云南医药

2010年第6期

内容加载中请稍等...